From 12 to 14 June 2026, the IMMUPARKNET community gathered in the historic city of Coimbra, Portugal, for the Final Annual Conference of COST Action...
IMMUPARKNET, the leading network dedicated to researching the role of immunity and neuroinflammation in Parkinson’s Disease, proudly announces the participation of its prominent members at...
For more than 20 years, the Dopamine Meetings have provided a collaborative forum for scientists from diverse backgrounds to share their latest work and ideas....
📍 Faculty of Medicine, University of Coimbra (FMUC), Portugal📅 12–14 June 2026 We are pleased to present the final program of the 4th and final...
Seville, 9–10 April 2026 The second edition of the IMMUPARKNET Training School was held at the Instituto de Biomedicina de Sevilla (IBiS) in Seville, Spain,...
A new study published in “The Lancet Neurology” investigates whether azathioprine, a common immunosuppressant, could represent a breakthrough in slowing the progression of Parkinson’s Disease...
We are pleased to announce that the fourth and final Annual Conference of the IMMUPARKNET Action will take place in Coimbra, Portugal, from 12 to...
COST Action IMMUPARKNET is pleased to present its Gender Equality Plan (GEP) 2025, a strategic document that reflects on the progress made and sets out...
We are pleased to invite you to the upcoming IMMUPARKNET Training School on Immune Profiling in Parkinson’s Disease: Designing Observational Clinical Studies Venue: Instituto de...
On the past 17-19 October 2025, members of IMMUPARKNET COST Action met at the The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus, to discuss...
We’re thrilled to share the latest publication from our Working Group 3 (WG3) at IMMUPARKNET COST Action 21117, published in npj Parkinson’s Disease! Entitled “Recommendations...
We invite you to a stimulating discussion on May 15, 2025, at 3:00 PM CET, organized as part of the COST Action CA21117. This online...